Genetically Modified Cells TRIZ Cases

Applying heat and low pH degrades released DNA without extra chemicals, eliminating complex equipment needs.

Transplanting placenta-derived neural progenitor cells into the brain to generate functional neurons.

Genetically modifying autologous hematopoietic stem cells via CRISPR/Cas9 integration at the CCR5 locus enables stable therapeutic protein expression.

Segmented virulence plasmids under synthetic control resolve pleiotropic complexity, improving transformation efficiency in recalcitrant plants.

Transient transcription factor expression with feeder layers enables indefinite hiNSC self-renewal without neurosphere formation or phenotype loss.

Small molecule modulators regulate host protein activity to decouple cell productivity from post-translational modification consistency.

CRISPR-mediated B2M deletion prevents autocrine signaling and graft-versus-host disease in allogeneic adoptive cell therapy.

Directly reprogram fibroblasts into dendritic cells via four transcription factors, bypassing slow stem cell generation.

Reprogram chondrocytes into induced pluripotent stem cells to regenerate cartilaginous tissue, resolving inadequate tissue repair and integration.

Genetically engineered reporter cell lines detect nitric oxide production and endothelial differentiation via luciferase fusion proteins.

A plant cell system uses transient expression to produce mature and active Amb a 1 allergen in high yields.

Applying proteasome and ERAD inhibitors during CHO cell line development to increase recombinant polypeptide yield while managing selection complexity.

Optimizing EL4-B5 cell density resolves the contradiction between productivity and process control, increasing antigen-binding frequency.

Rag1 and Rag2 knockout pluripotent stem cells bearing specific T cell receptors prevent antigen specificity loss and graft-versus-host reactions.

Forced transcription factor expression converts human pluripotent stem cells into hemogenic endothelium.

Adapting CHO-DXB11 cells to serum-free suspension medium resolves the trade-off between high cell density and culture stability, increasing antibody yield.

Engineered multi-potent cells differentiate into functional granulosa precursors to resolve isolation complexity and boost steroidal hormone production.

Transient NKX2-1 and PAX8 expression drives definitive endoderm differentiation, enabling mature hormone production in thyroid models.

Transformed T cells expressing 4-1BBL and mbIL-21 act as feeder layers to overcome low proliferation rates in NK cell culture.

Simultaneous knockout of CISH and CD38 via CRISPR resolves the trade-off between NK cell cytotoxicity and persistence against cancer targets.

Engineered innate lymphoid cells express chimeric antigen receptors to overcome CD8+ T cell exhaustion in solid tumors.

Rice plants produce recombinant human serum albumin to replace animal-derived components and eliminate pathogen contamination risks.

PTD-MYC fusion polypeptide drives nuclear translocation of MYC in immune cells, boosting antitumor activity beyond isolated lymphocyte limits.

Targeted genetic modulation of CHO cell metabolic pathways balances energy production and protein folding to resolve bottlenecks in titer and culture longevity.